Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021
Manoj Murhekar, Tarun Bhatnagar, Jeromie Wesley Vivian Thangaraj, et al.
International Journal of Infectious Diseases (2021) Vol. 108, pp. 145-155
Open Access | Times Cited: 118

Showing 26-50 of 118 citing articles:

COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks
Chandran Murugan, Sharmiladevi Ramamoorthy, Guru Prasad Kuppuswamy, et al.
International Journal of Biological Macromolecules (2021) Vol. 193, pp. 1165-1200
Open Access | Times Cited: 22
Forecast of the COVID-19 trend in India: A simple modelling approach
Haitao Song, Guihong Fan, Shi Zhao, et al.
Mathematical Biosciences & Engineering (2021) Vol. 18, Iss. 6, pp. 9775-9786
Open Access | Times Cited: 21
SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey
Abbas Hoballah, Rana El Haidari, Ghina Siblany, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Dynamics of SARS-CoV-2 seroassay sensitivity: a systematic review and modelling study
Nana Owusu‐Boaitey, Timothy Russell, Gideon Meyerowitz‐Katz, et al.
Eurosurveillance (2023) Vol. 28, Iss. 21
Open Access | Times Cited: 8
Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study
Mohammad Zamani, Hossein Poustchi, Zahra Mohammadi, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 13
COVID-19 in Tunisia (North Africa): Seroprevalence of SARS-CoV-2 in the General Population of the Capital City Tunis
Ines Cherif, Ghassen Kharroubi, Sana Châabane, et al.
Diagnostics (2022) Vol. 12, Iss. 4, pp. 971-971
Open Access | Times Cited: 12
Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021
Rubhana Raqib, Protim Sarker, Evana Akhtar, et al.
PLoS ONE (2022) Vol. 17, Iss. 5, pp. e0268093-e0268093
Open Access | Times Cited: 12
Creation of a pandemic memory by tracing COVID-19 infections and immunity in Luxembourg (CON-VINCE)
Olena Tsurkalenko, Dmitry Bulaev, Marc Paul O’Sullivan, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
A Mixture Model for Estimating SARS-CoV-2 Seroprevalence in Chennai, India
Matt D. T. Hitchings, Eshan U. Patel, Rifa Khan, et al.
American Journal of Epidemiology (2023) Vol. 192, Iss. 9, pp. 1552-1561
Open Access | Times Cited: 6
SARS-CoV-2 Seroprevalence in Individuals With Type 1 and Type 2 Diabetes Compared With Controls
Alpesh Goyal, Yashdeep Gupta, Mani Kalaivani, et al.
Endocrine Practice (2021) Vol. 28, Iss. 2, pp. 191-198
Open Access | Times Cited: 14
Modelling the first wave of COVID-19 in India
Dhiraj Kumar Hazra, Bhalchandra S. Pujari, Snehal M. Shekatkar, et al.
PLoS Computational Biology (2022) Vol. 18, Iss. 10, pp. e1010632-e1010632
Open Access | Times Cited: 10
Hybrid Deep Learning Algorithm for Forecasting SARS-CoV-2 Daily Infections and Death Cases
Fehaid Alqahtani, Mostafa Abotaleb, Ammar Kadi, et al.
Axioms (2022) Vol. 11, Iss. 11, pp. 620-620
Open Access | Times Cited: 10
Trend in Sensitivity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Serology One Year After Mild and Asymptomatic Coronavirus Disease 2019 (COVID-19): Unpacking Potential Bias in Seroprevalence Studies
Christopher R. Bailie, Yeu Yang Tseng, Louise Carolan, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 1, pp. e357-e360
Open Access | Times Cited: 9
High failure rate of ChAdOx1-nCoV19 immunization against asymptomatic infection in healthcare workers during a Delta variant surge
Rajat Ujjainiya, Akansha Tyagi, Viren Sardana, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Seroprevalence of SARS-CoV-2 in Brazil: A systematic review and meta-analysis
Gerusa Maria Figueiredo, Fátima Mitiko Tengan, Sérgio Roberto de Souza Leão da Costa Campos, et al.
Clinics (2023) Vol. 78, pp. 100233-100233
Open Access | Times Cited: 4
Large and unequal life expectancy declines during the COVID-19 pandemic in India in 2020
Aashish Gupta, Payal Hathi, Murad Banaji, et al.
Science Advances (2024) Vol. 10, Iss. 29
Open Access | Times Cited: 1
The INDSCI-SIM model for COVID-19 in India
Dhiraj Kumar Hazra, Bhalchandra S. Pujari, Snehal M. Shekatkar, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 11
Social Factors Associated With Adherence to Preventive Behaviors Related to COVID-19 Among Rural and Semi-urban Communities in Western Maharashtra, India
Suhas Shewale, Suvarna Sane, Dhammasagar Ujagare, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 11
Epidemiological findings for the first and second waves of COVID-19 pandemic in Maharashtra, India
Pratip Shil, Nitin M. Atre, Babasaheb V. Tandale
Spatial and Spatio-temporal Epidemiology (2022) Vol. 41, pp. 100507-100507
Open Access | Times Cited: 7
Seroprevalence and infection attack rate of COVID-19 in Indian cities
Yiming Fei, Hainan Xu, Xingyue Zhang, et al.
Infectious Disease Modelling (2022) Vol. 7, Iss. 2, pp. 25-32
Open Access | Times Cited: 7
Seroprevalence and risk factors for COVID-19 in the metropolis of the Brazilian Amazon
Maria Karoliny da Silva Torres, Felipe Teixeira Lopes, Aline Cecy Rocha de Lima, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 7
The Spatial Association of Demographic and Population Health Characteristics with COVID‐19 Prevalence Across Districts in India
Sarbeswar Praharaj, Harsimran Kaur, Elizabeth A. Wentz
Geographical Analysis (2022) Vol. 55, Iss. 3, pp. 427-449
Open Access | Times Cited: 7
Seroprevalence of immunoglobulin G antibodies against SARS-CoV-2 in children and adolescents in Delhi, India, from January to October 2021: a repeated cross-sectional analysis
Pragya Sharma, Saurav Basu, Suruchi Mishra, et al.
Osong Public Health and Research Perspectives (2022) Vol. 13, Iss. 3, pp. 184-190
Open Access | Times Cited: 7
A Bioinformatics Tool for Predicting Future COVID-19 Waves Based on a Retrospective Analysis of the Second Wave in India: Model Development Study
Ashutosh Kumar, Adil Asghar, Prakhar Dwivedi, et al.
JMIR Bioinformatics and Biotechnology (2022) Vol. 3, Iss. 1, pp. e36860-e36860
Open Access | Times Cited: 7
Generalized anxiety and sleep quality among health care professionals during the COVID-19 pandemic: a cross-sectional study from a tertiary healthcare institution in Eastern India
Bijaya Nanda Naik, Sanjay Pandey, Rajath Rao, et al.
Osong Public Health and Research Perspectives (2022) Vol. 13, Iss. 1, pp. 51-61
Open Access | Times Cited: 6

Scroll to top